Due to various study designs with variable objectives and believability, evidence on preventing Alzheimer's disease (AD) is difficult to understand. Over the last few decades, there have been significant global efforts to update and upgrade the knowledge on how to prevent Alzheimer's disease (AD), which accounts for roughly two-thirds of all dementia cases and affects up to 20% of people over the age of 80. Nonetheless, inconsistency among conclusions and varying levels of credibility resulting from the large variety of study methods are major concerns in the discipline. Prevention programming that is evidence-based (EB) comprises of interventions and policies that have been proved to be successful in preventing the initiation and continuation of substance use and other problem behaviors through rigorous evaluations.
Important Alert:
X
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Electrophysiology and alzheimer's pathology: A scoping review on eeg correlations with CSF biomarkers
Charikleia Karastamati, University of Pavia, Italy
Title : The vital role of care homes in supporting individuals with neurological conditions
Akankunda Veronicah, Golden Age Elderly Homes Kampala, Uganda
Title : Semantic-based memory-encoding strategy in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised
Karen P Y Liu, Western Sydney University, Hong Kong